Combination pharmaceutical therapies for obesity.
The anti-obesity medications available at present achieve a rather modest degree of weight loss that falls below the expectations of clinicians as well as consumers. Several combination drug therapies are in development with the aim of achieving better results that would be clinically more meaningful in the reduction of obesity-related health risks. This paper discusses the pros and cons of combination therapies, and the ongoing research in this area.
Kishore M
KM
Gadde
David B
DB
Allison
D019440:Anti-Obesity Agents / Q000008:administration & dosage*; D015992:Body Mass Index; D004359:Drug Therapy, Combination; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D015431:Weight Loss / Q000187:drug effects / Q000502:physiology
D019440:Anti-Obesity Agents